10
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Osteoprotegerin and rank ligand expression in prostate cancer.

      1 , , , , , ,
      Urology
      Elsevier BV

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          To investigate the expression of osteoprotegerin (OPG) and RANK ligand (RANKL) in human prostatic tissues. The factors regulating the increased turnover associated with prostate cancer (CaP) bone metastasis are unknown. OPG and RANKL are recently identified regulators of bone resorption and bone remodeling.

          Related collections

          Author and article information

          Journal
          Urology
          Urology
          Elsevier BV
          1527-9995
          0090-4295
          Apr 2001
          : 57
          : 4
          Affiliations
          [1 ] Department of Urology, University of Washington, Seattle, Washington, USA.
          Article
          S0090-4295(00)01122-5
          10.1016/s0090-4295(00)01122-5
          11306358
          a43a689a-5463-4a19-b1e5-d96fa37ca10d
          History

          Comments

          Comment on this article